San Francisco, 11
April , Urolithiasis
Management Devices Market Analysis By Treatment Type (Extracorporeal Shock Wave
Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy,
Other Treatments (Watchful Waiting, Parathyroid Gland Surgery)), By End Use
(Hospitals & Clinics, Ambulatory Surgical Centers), And Segment Forecasts
To 2024
The global urolithiasis management devices market was
valued at USD 1.27 billion in 2015 and is expected to be valued at USD 1.93
billion by 2024. The alarming growth in the incidence rate of urinary stones,
over the years, is responsible for the advancements in the treatment options.
European Association of Urology states that it is one of the most common
lifestyle disorders with a 10% prevalence rate and requires a systematic
treatment approach.
Urolithiasis means formation of
stones in the urinary system, mainly including the kidney, ureters, and the
bladder. It is a major healthcare concern in the high end countries such as the
U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases.
Urolithiasis can be managed with the help of lifestyle changes, controlled
diet, or basic medication. However, various treatment approaches need to be
adopted for the removal of large stones that cause severe pain. Depending upon
the stone size, location in the body, and anatomical variations in the
urogenital tract, invasive or noninvasive stone removal procedures are available.
For instance, smaller stones can be tackled with external shock waves
(extracorporeal shock wave lithotripsy), while larger stones can be removed
through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).
Smaller stones generally do not
require surgical interventions and can be cured with the help of medication and
a healthy diet. However, larger stones necessitate different approaches for
their elimination. Extracorporeal lithotripsy is one of the common treatments
employed for stone elimination and held a majority market share in the year
2015. Intracorporeal lithotripsy treatments spot and reduce the stones to
smaller pieces with the help of endoscopy. For the disintegration of stones,
ultrasound or laser techniques are used to enable the passage of smaller
fragments through the urinary system. Owing to the effective stone-free rate
offered by intracorporeal lithotripsy, it is likely to be preferred as a
treatment option during the forecast period.
Furthermore, percutaneous
nephrolithotomy is a surgical approach deployed to eliminate larger stones
where extracorporeal or intracorporeal lithotripsies prove to be ineffective
and typically require a week’s hospitalization.
Ambulatory surgical centers are
gaining popularity over traditional hospital and clinic settings due to the
time and cost saving benefits. As a result, this end-use segment is expected to
record a lucrative growth rate during the forecast period. Introduction of
novel surgical technologies, such as endoscopy and micro accessories including
guidewires, scalpels, and baskets, to effectively expel stones from the urinary
system in a short time has enhanced the overall acceptability of minimally
invasive surgeries.
Access Full Research
Report On Urolithiasis Management Devices Market Analysis:
Further Key Findings from the Study Suggest:
·
Urinary stones are highly
prevalent worldwide with a 15% global target population and the recurrence rate
of 50%. Men are more susceptible to developing renal stones than women.
·
Adoption and acceptance of
intracorporeal lithotripsy contributed to more than 95% stone-free rate, which
will render it the most preferred alternative over extracorporeal and
subcutaneous treatments. On the other hand, ambulatory surgical centers will
grow at a higher rate due to the associated benefits of lower cost and shorter
perioperative time.
·
The upward trend in the
adoption of sedentary lifestyle coupled with increased consumption of unhealthy
food in the developed countries is responsible for the rising incidence of
kidney stones. Ambulatory surgical service providers are expected to experience
a surge in the treatment demand as a result of the unhealthy lifestyle changes,
especially in the developed countries.
Browse More Reports Of This Category By
Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
urolithiasis management devices market by treatment type, end use, and region:
Treatment Type Outlook (Market
revenue in USD Million, 2013 - 2024)
·
Extracorporeal Shock Wave
Lithotripsy (ESWL)
·
Intracorporeal Lithotripsy
·
Percutaneous Nephrolithotomy
·
Other Treatments
End Use Outlook (Market Revenue
in USD Million, 2013 - 2024)
·
Hospitals & Clinics
·
Ambulatory Surgical Centers
Regional Outlook (Market
Revenue in USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa
o
South Africa
Access Full Press Release of this Report: https://www.grandviewresearch.com/press-release/global-urolithiasis-management-devices-market
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment